Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fluralaner Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN113461653B offers a catalyst-free, ambient temperature route for Fluralaner intermediates, ensuring supply chain stability and reduced manufacturing costs for veterinary APIs.
Patent CN115304472A reveals a cost-effective 5-step route for Fluralaner intermediates. Discover how this non-cyanide process ensures high purity and supply stability.